Allosteric Modulator Discovery: From Serendipity to Structure-Based Design

Journal of Medicinal Chemistry
2019.0

Abstract

Allosteric modulators bound to structurally diverse allosteric sites can achieve better pharmacological advantages than orthosteric ligands. The discovery of allosteric modulators, however, has been traditionally serendipitous, owing to the complex nature of allosteric modulation. Recent advances in the understanding of allosteric regulatory mechanisms and remarkable availability of structural data of allosteric proteins and modulators, as well as their complexes, have greatly contributed to the development of various computational approaches to guide the structure-based discovery of allosteric modulators. This Perspective first outlines the evolution of the allosteric concept and describes the advantages and hurdles facing allosteric modulator discovery. The current available computational approaches, together with experimental approaches aiming to highlight allosteric studies, are then highlighted, emphasizing successful examples with their combined applications. We aimed to increase the awareness of the feasibility of the structure-based discovery of allosteric modulators using an integrated computational and experimental paradigm.

Knowledge Graph

Similar Paper

Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
Journal of Medicinal Chemistry 2019.0
Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design
Journal of Medicinal Chemistry 2019.0
Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective
Bioorganic & Medicinal Chemistry Letters 2017.0
A double effect molecular switch leads to a novel potent negative allosteric modulator of metabotropic glutamate receptor 5
Med. Chem. Commun. 2014.0
Activation of the γ-Aminobutyric Acid Type B (GABA<sub>B</sub>) Receptor by Agonists and Positive Allosteric Modulators
Journal of Medicinal Chemistry 2015.0
Discovery, Synthesis, and Molecular Pharmacology of Selective Positive Allosteric Modulators of the δ-Opioid Receptor
Journal of Medicinal Chemistry 2015.0
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease
European Journal of Medicinal Chemistry 2017.0
Discovery of novel positive allosteric modulators of the α7 nicotinic acetylcholine receptor: Scaffold hopping approach
European Journal of Medicinal Chemistry 2021.0
Positive and Negative Allosteric Modulators ofN-Methyl-<scp>d</scp>-aspartate (NMDA) Receptors: Structure–Activity Relationships and Mechanisms of Action
Journal of Medicinal Chemistry 2019.0
Discovery of a Negative Allosteric Modulator of GABA<sub>B</sub> Receptors
ACS Medicinal Chemistry Letters 2014.0